Rubicon Research Limited (BOM:544578)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Pharmaceutical Products (Generics, Speciality, API, Related Services, Etc.)	17.54B	12.84B	8.54B	3.94B	3.14B
Total	17.54B	12.84B	8.54B	3.94B	3.14B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
India	62.93M	99.67M	109.92M	118.31M	54.94M
USA	17.37B	12.65B	8.32B	3.67B	2.91B
Others	105.05M	93.82M	111.84M	147.25M	168.46M
Total	17.54B	12.84B	8.54B	3.94B	3.14B

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error